ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $18,705,000 | +6.7% | 382,051 | +4.3% | 0.00% | 0.0% |
Q3 2016 | $17,526,000 | -9.9% | 366,279 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $19,451,000 | +14.1% | 362,561 | -4.9% | 0.00% | 0.0% |
Q1 2016 | $17,041,000 | +17.3% | 381,053 | +0.1% | 0.00% | +50.0% |
Q4 2015 | $14,529,000 | +15.4% | 380,751 | -3.7% | 0.00% | 0.0% |
Q3 2015 | $12,586,000 | -23.5% | 395,403 | -20.6% | 0.00% | -33.3% |
Q2 2015 | $16,444,000 | -24.8% | 497,857 | -6.3% | 0.00% | 0.0% |
Q1 2015 | $21,865,000 | -1.3% | 531,100 | -2.4% | 0.00% | -25.0% |
Q4 2014 | $22,158,000 | +13.7% | 543,899 | +2.3% | 0.00% | +33.3% |
Q3 2014 | $19,484,000 | -11.4% | 531,479 | +11.9% | 0.00% | -25.0% |
Q2 2014 | $22,000,000 | +5.4% | 474,864 | -6.5% | 0.00% | 0.0% |
Q1 2014 | $20,869,000 | +40.4% | 507,764 | +30.4% | 0.00% | +33.3% |
Q4 2013 | $14,865,000 | +61.2% | 389,533 | +0.9% | 0.00% | +50.0% |
Q3 2013 | $9,223,000 | +43.4% | 386,068 | +2.0% | 0.00% | +100.0% |
Q2 2013 | $6,432,000 | – | 378,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |